double stranded DNA (dsDNA) ANTIBODY

The Double Stranded DNA (dsDNA) Antibody test detects antibodies directed against native double‑stranded DNA in the blood, most commonly measured as anti‑dsDNA IgG by quantitative immunoassay. It uses a venous serum sample and sensitive laboratory methods (eg, ELISA or immunofluorescence) to report antibody levels and titer, which are clinically valuable for diagnosing and tracking systemic lupus erythematosus (SLE).

This test is primarily used to help confirm SLE and to monitor disease activity — rising anti‑dsDNA levels often correlate with flares, particularly lupus nephritis. At-home collection by licensed Dubai phlebotomists with rapid, accredited laboratory reporting makes it convenient for patients in the UAE to obtain timely, actionable results for physician review and treatment decisions.

• Anti‑double stranded DNA (anti‑dsDNA) — IgG (quantitative)
• Anti‑dsDNA antibody titer / concentration (IU/mL or AU/mL)
• Qualitative result (Negative / Equivocal / Positive) with laboratory reference range

• Initial evaluation when systemic lupus erythematosus (SLE) is suspected
• When patients with known SLE develop new or worsening symptoms (eg, rash, arthralgia, fatigue)
• Suspected lupus nephritis or unexplained proteinuria/haematuria
• Monitoring disease activity during treatment or after medication changes
• Periodic follow‑up to detect early serologic flares before clinical deterioration

• Quantitative measurement of anti‑dsDNA to aid diagnosis and monitor SLE activity
• At‑home venous blood collection by licensed Dubai phlebotomists for patient convenience
• Accredited laboratory analysis with rapid reporting to your Touch Connect account and treating physician
• Results that support timely clinical decisions about immunosuppression and specialist referral
• Suitable for serial testing to track trends in antibody levels over time

• At‑home venous blood draw performed by a licensed phlebotomist in Dubai
• No fasting required; follow normal medications unless otherwise instructed by your physician
• Provide a list of current immunosuppressive or biologic therapies to the collector
• Ensure accurate patient identification and share treating physician details for direct result delivery